Share info

Roche's non-voting equity securities and Roche bearer shares are listed on SIX Swiss Exchange. Roche’s American Depositary Receipt (ADR) is listed on OTCQX International Premier under the ticker RHHBY.

Security
Roche bearer share
Roche NES
Roche ADR
Trading
SIX
SIX
OTCQX
Reuters
RO.S
ROG.S
RHHBY
Bloomberg
RO SW
ROG SW
RHHBY
SIX Swiss Exchange
RO
ROG
ISIN
CH0012032113
CH0012032048
Type
Number of bearer shares (nominal value CHF 1.-)
Number of non-voting equity securities (NES)
Number
106,691,000
702,562,700

The Company has a share capital of CHF 106,691,000, divided into 106,691,000 fully paid bearer shares with a nominal value of 1 Swiss franc each. There are no limitations on the transfer of these shares and no shares with maximum voting rights (please refer to § 3ss. of the Articles of Incorporation of Roche Holding Ltd.).

In addition, 702,562,700 non-voting equity securities have been issued in bearer form. Roche’s non-voting equity securities and the rights pertaining thereto are described in §4ss. of the Articles of Incorporation of Roche Holding Ltd.

For more information, please read the Articles of Incorporation.

The share capital of Roche Holding Ltd, which is the Group’s parent company, amounts to CHF 106,691,000 consisting of 106,691,000 fully paid up bearer shares with a nominal value of CHF 1 each. As the shares are bearer shares, the Group does not maintain a register of shareholders.

At 2 February 2022, based on information supplied to the Group, a shareholder group with pooled voting rights owned 72,018,000 shares representing 67.50% of the issued shares. These figures do not include any shares without pooled voting rights held outside this group by individual members of the group. Since 5 December 2019, the shareholder group consists of Mr André Hoffmann, Ms Marie-Anne Hoffmann, Ms Vera Michalski, Mr Alexander Hoffmann, Mr Frederic Hoffmann, Ms Isabel Hoffmann, Mr Lucas Hoffmann, Ms Marina Hoffmann, Ms Kasia Barbotin-Larrieu, Ms Tatiana Fabre, Mr Andreas Oeri, Ms Catherine Oeri, Ms Sabine Duschmalé, Mr Jörg Duschmalé, Mr Lukas Duschmalé, the charitable foundation Wolf and Artuma Holding Ltd. The shareholder pooling agreement has existed since 1948. In 2009, the duration of the pool was extended for an indefinite period.

At 2 February 2022, based on information supplied to the Group, Ms Maja Oeri, formerly a member of the pool, held 8,091,900 shares independently of the pool, representing 7.58% of the issued shares.

Equity research on Roche is provided by the following institutions. We provide the names of institutions for your convenience only. We do not endorse or express any opinion on their reports and expressly disclaim any liability for any of their statements and for the use of such third party information. The list does not purport to be complete, correct or representative. The list may be updated from time to time, but no assurance is given that the list is current or accurate as of any point in time.

Institutions
  • Alliance Bernstein

  • Bank of America

  • Bank Vontobel AG

  • Barclays

  • Berenberg

  • Bryan Garnier & Cie

  • Citi

  • Cowen & Co

  • Credit Suisse

  • Deutsche Bank

  • Exane BNP Paribas

  • Goldman Sachs

  • HSBC

  • Intron Health

  • Jefferies

  • JPMorgan

  • Kepler Cheuvreux

  • Liberum

  • Mirabaud Securities

  • Morgan Stanley

  • Morningstar Inc

  • New Street Research

  • ODDO Securities

  • Redburn (Europe) Limited

  • Société Générale

  • Stifel

  • UBS

  • Wolfe Research

  • Zürcher Kantonalbank (ZKB)

The next Annual General Meeting of Roche Holding Ltd is expected to take place on 14 March 2023.

Timetable for payment of the 2021 dividend

Roche Non-Voting Equity Securities and Roche Bearer Shares
AGM / Declaration date1
Ex-dividend date2
Record date3
Payment date
Tuesday 15 March 2022
Thursday 17 March 2022
Friday 18 March 2022
Monday 21 March 2022

Timetable for payment of the 2021 dividend

Roche ADR (American Depositary Receipt)
AGM / Declaration date1
Ex-dividend date2
Record date3
Payment date
Tuesday 15 March 2022
Thursday 17 March 2022
Friday 18 March 2022
Monday 28 March 2022
Roche Non-Voting Equity Securities and Roche Bearer Shares
AGM / Declaration date1
Ex-dividend date2
Record date3
Payment date
Tuesday 16 March 2021
Thursday 18 March 2021
Friday 19 March 2021
Monday 22 March 2021
Roche ADR (American Depositary Receipt)
AGM / Declaration date1
Ex-dividend date2
Record date3
Payment date
Tuesday 16 March 2021
Thursday 18 March 2021
Friday 19 March 2021
Monday 29 March 2021
  1. Declaration date is the date of approval of the proposed dividend at the Annual General Meeting

  2. Ex-dividend date is the first date where trading takes place without dividend

  3. Record date is the last date on which the security must be held in custody in order to be eligible to receive dividend (as settlement typically takes place trading day + 3 days)

  4. Beginning in 2019, Roche Holding Ltd dividend to ADR holders will be paid in two stages. The first payment will be less 35% Swiss withholding tax, payable one week after Swiss pay date. Those eligible holders reclaiming Swiss withholding tax will receive a second payment once the reclaim process is completed.

This investor tool provides advanced analysis of total returns over time including dividend history and a calculator that can be used to determine the value and total return of your investment.

Year
Number of shares (nominal value: CHF 1.00)
Number of non-voting equity securities (Genussscheine) (no nominal value)
Total
2017
160'000'000
702'562'700
862,562,700
2018
160'000'000
702'562'700
862,562,700
2019
160'000'000
702'562'700
862,562,700
2020
160'000'000
702'562'700
862,562,700
2021
160'000'000
702'562'700
862,562,700
Data per share and non-voting equity security in CHF
Year
Earnings (basic)
Earnings (diluted)
Core earnings (basic)
Core earnings (diluted)
Equity attributable to Roche shareholders
Dividend c)
Stock price of share b)
- Opening
- High
- Low
- Year-end
Stock price of non-voting equity security (Genussschein) b)
- Opening
- High
- Low
- Year-end
2017
10.12
10.04
15.47
15.34
30.97
8.30
238.00
271.75
230.40
246.20
232.60
272.60
227.70
246.50
2018
12.29
12.21
18.25
18.14
32.33
8.70
246.20
258.00
211.60
239.40
246.50
259.50
207.70
243.40
2019
15.77
15.62
20.35
20.16
38.27
9.00
239.40
312.20
239.40
307.60
243.40
317.25
243.40
314.00
2020
16.73
16.52
19.40
19.16
42.60
9.10
307.60
352.20
267.40
310.00
314.00
354.05
274.45
309.00
2021
16.41
16.23
20.07
19.84
30.60
9.30
310.00
420.00
303.80
408.80
309.00
383.60
297.50
379.10
Market capitalisation in millions of CHF
Year
Year-end
2017
210'426
2018
207'328
2019
267'684
2020
263'776
2021
306'601
Key ratios (year-end)
Year
Dividend yield of shares in %
Dividend yield of non-voting equity securities (Genussscheine) in %
Price/earnings of shares
Price/earnings of non-voting equity securities (Genussscheine)
2017
3.4
3.4
25
25
2018
3.6
3.6
20
20
2019
2.9
2.9
20
20
2020
2.9
2.9
19
19
2021
2.3
2.5
25
23

a) Each non-voting equity security (Genussschein) confers the same rights as any of the shares to participate in the available earnings and any remaining proceeds from liquidation following repayment of the nominal value of the shares and the participation certificate capital (if any). Shares and non-voting equity securities are listed on the SIX Swiss Exchange. Roche Holding Ltd has no restrictions as to ownership of its shares or non-voting equity securities.

b) All stock price data reflect daily closing prices.

c) 2021 dividend proposed by the Board of Directors.

Yearly Dividend Payout
Number of shares and non-voting equity securities a)